{"id":4512,"date":"2025-09-19T13:20:49","date_gmt":"2025-09-19T10:20:49","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4512"},"modified":"2025-09-19T17:03:29","modified_gmt":"2025-09-19T14:03:29","slug":"fda-grants-orphan-drug-designation-to-ns-051-ncnp-04-for-the-treatment-of-duchenne-muscular-dystrophy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/zh\/fda-grants-orphan-drug-designation-to-ns-051-ncnp-04-for-the-treatment-of-duchenne-muscular-dystrophy\/","title":{"rendered":"FDA \u6388\u4e88 NS-051\/NCNP-04 \u5b64\u513f\u836f\u8d44\u683c\u8ba4\u5b9a\uff0c\u7528\u4e8e\u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><strong>Nippon Shinyaku \u5ba3\u5e03\uff0c\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40 (FDA) \u5df2\u6388\u4e88 NS-051\/NCNP-04 \u5b64\u513f\u836f\u8d44\u683c\u8ba4\u5b9a\uff0c\u8be5\u836f\u7269\u6b63\u5728\u5f00\u53d1\u7528\u4e8e\u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7 (DMD)\u3002<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u7f8e\u56fd\u5b64\u513f\u836f\u8d44\u683c\u8ba4\u5b9a\u6388\u4e88\u6cbb\u7597\u7f8e\u56fd\u60a3\u8005\u4eba\u6570\u5c11\u4e8e20\u4e07\u7684\u75be\u75c5\u7684\u836f\u7269\uff0c\u4ee5\u652f\u6301\u5176\u5f00\u53d1\u548c\u8bc4\u4f30\u3002\u5b64\u513f\u836f\u8d44\u683c\u8ba4\u5b9a\u8d4b\u4e88NS-051\/NCNP-04\u4e03\u5e74\u7684\u72ec\u5bb6\u5e02\u573a\u63a8\u5e7f\u6743\u3002 <a href=\"https:\/\/dmdwarrior.com\/zh\/fda-grants-rare-pediatric-disease-designation-to-nippon-shinyakus-exon-51-skipping-study-ns-051-ncnp-04\/\" target=\"_blank\" rel=\"noreferrer noopener\">NS-051\/NCNP-04 \u5df2\u4e8e 2025 \u5e74 1 \u6708\u88ab FDA \u6388\u4e88\u7f55\u89c1\u513f\u79d1\u75be\u75c5\u79f0\u53f7\u3002<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DMD \u662f\u4e00\u79cd\u7531\u808c\u8425\u517b\u4e0d\u826f\u86cb\u767d (dystrophin) \u7f3a\u4e4f\u5f15\u8d77\u7684\u8fdb\u884c\u6027\u808c\u8089\u840e\u7f29\u75c7\u3002\u5b83\u4f1a\u5bfc\u81f4\u9aa8\u9abc\u808c\u3001\u5fc3\u808c\u548c\u547c\u5438\u808c\u65e0\u529b\u3002\u591a\u79cd\u7c7b\u578b\u7684\u57fa\u56e0\u7a81\u53d8\u53ef\u5bfc\u81f4 DMD\uff0cNS-051\/NCNP-04 \u6b63\u5728\u5f00\u53d1\u4e2d\uff0c\u7528\u4e8e\u6cbb\u7597\u5df2\u786e\u8bca\u57fa\u56e0\u7a81\u53d8\u4e14\u9002\u5408\u63a5\u53d7 51 \u53f7\u5916\u663e\u5b50\u8df3\u8dc3\u7597\u6cd5\u7684\u60a3\u8005\u3002\u4e86\u89e3\u66f4\u591a\uff1a <a href=\"https:\/\/dmdwarrior.com\/zh\/mutations-and-deletions-amenable-to-exon-51-skipping-therapies-dmd\/\" target=\"_blank\" rel=\"noreferrer noopener\">\u9002\u5408\u5916\u663e\u5b50 51 \u8df3\u8dc3\u7597\u6cd5\u7684\u7a81\u53d8\u548c\u7f3a\u5931<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">NS-051\/NCNP-04\u662f\u7531\u65e5\u672c\u56fd\u7acb\u795e\u7ecf\u7cbe\u795e\u75c5\u5b66\u7814\u7a76\u4e2d\u5fc3\uff08NCNP\uff0c\u4e1c\u4eac\u5c0f\u5e73\u5e02\uff1b\u4ee3\u8868\u7406\u4e8b\u957f\uff1a\u4e2d\u8fbc\u548c\u4e4b\uff09\u4e0eNippon Shinyaku\u5171\u540c\u53d1\u73b0\u7684\u53cd\u4e49\u5be1\u6838\u82f7\u9178\u3002NS-051\/NCNP-04\u8df3\u8fc7\u4e86\u808c\u8425\u517b\u4e0d\u826f\u86cb\u767d\u57fa\u56e0\u7684\u90e8\u5206\u9057\u4f20\u4fe1\u606f\uff0c\u751f\u6210\u4e86\u94fe\u957f\u7565\u77ed\u7684\u529f\u80fd\u6027\u808c\u8425\u517b\u4e0d\u826f\u86cb\u767d\uff0c\u6709\u671b\u8d77\u5230\u6291\u5236\u808c\u8089\u529f\u80fd\u8870\u9000\u7684\u6548\u679c\u3002<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u5728Nippon Shinyaku\uff0c\u6211\u4eec\u6ee1\u6000\u4f7f\u547d\u611f\u5730\u81f4\u529b\u4e8e\u5f00\u53d1\u9488\u5bf9\u96be\u6cbb\u6027\u548c\u7f55\u89c1\u75c5\u7684\u521b\u65b0\u65b0\u7597\u6cd5\uff0c\u79ef\u6781\u52aa\u529b\u5c3d\u5feb\u4e3aDMD\u60a3\u8005\u5e26\u6765\u65b0\u7684\u6cbb\u7597\u9009\u62e9\u3002<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u4e86\u89e3\u66f4\u591a<\/strong>: <a href=\"https:\/\/dmdwarrior.com\/zh\/exon-51-skipping-therapies-dmd\/\">\u5373\u5c06\u63a8\u51fa\u7684\u7528\u4e8e\u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u7684\u5916\u663e\u5b50 51 \u8df3\u8dc3\u7597\u6cd5<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Nippon Shinyaku announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to NS-051\/NCNP-04 which is being developed for the treatment of Duchenne Muscular Dystrophy (DMD). The Orphan Drug Designation in the U.S. is granted for treatments for diseases affecting fewer than 200,000 patients in the U.S., supporting their development and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4514,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[122,193,421,194,136,192,195],"class_list":["post-4512","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-exon-51","tag-exon-51-skipping","tag-exon-51-skipping-therapy","tag-exon-51-treatment","tag-nippon-shinyaku","tag-ns-051-ncnp-04","tag-orphan-drug"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts\/4512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/comments?post=4512"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts\/4512\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/media\/4514"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/media?parent=4512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/categories?post=4512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/tags?post=4512"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}